

If so, you may have a possible legal case against the manufacturer of the potentially dangerous drug or medical product. Simply fill out the short form below and an experienced legal expert will contact you as soon as possible!
Added October 17th, 2006

A blue ribbon scientific panel has released a report that concludes that the drug safety system in the United States is seriously flawed, and focuses too much attention on the approval of new medication with not nearly enough time or resources devoted to the safety and side effects of medications that have already received approval.
The panel of experts was put together after the controversy over Vioxx, a cox-2 inhibitor manufactured by Vioxx, which was found to increase the risk of heart attacks and strokes, and was withdrawn from the market in 2004. Thousands of lawsuits have now been filed over Vioxx, by family members of those that have died as a result of taking the medication as well as those that have suffered heart attacks and strokes from taking the drug.
The panel has now called for a reform, and has made a number of recommendations, including fixed term contracts for the commissioner of the FDA, restrictions on certain commercials, improved packaging and warnings for newly approved medications.
One spokesperson for the panel stated: "Staff and resources devoted to pre-approval are substantially greater than those available post-approval."

Panel Says Drug Safety... | Printable Version (Opens In New Window)